The estrogens, a group of substances some of which are produced within the body, act much like the carcinogenic hydrocarbons under some conditions. At least five types of tumor appear among estrogen-treated mice; namely, mammary, uterine, hypophyseal, testicular, and lymphoid.8'" Other factors or influences are now known to be necessary for the realization of all of the above types of neoplasia in estrogen-treated mice except those of the uterine cervix. The additional factors or influences are those transmitted by parent or parents to their young; in other words, the tumors are strainlimited in their appearance. However, of the tumors mentioned only those of the mammary glands may appear frequently among the untreated control animals of the groups being considered at this time. 24 The intrinsic humoral environments in multiparous mice of the susceptible groups are adequate to provoke mammary neoplasia. The tumors of the other glands or tissues require, for their instigation, a more drastic or a different type of stimulation; hence their infrequent spontaneous appearance among the animals studied here.
The carcinogenic hydrocarbons were thought at one time to provoke tumors only in the immediately adjacent or subjacent tissues. It is now known, however, that mammary,4' 26 pulmonary,2' hepatic,25 or lymphoid5' 19, 20, 23 tumors may occur among mice given subcutaneous or percutaneous applications of carcinogenic hydrocarbons. Interestingly, transmitted or inherited factors also determine the nature of the response in animals given carcinogenic hydrocarbons. Carcinogens induce lymphoid tumors in mice of some strains but not in mice of other strains. In mice of strains that show a tendency to acquire lymphoid tumors spontaneously the carcinogen may increase the incidence or decrease the average age of onset of the disease.
The mice of strains which show a high incidence of lymphoid tumors subsequent to estrogen treatment may not acquire such tumors when subjected to carcinogens. 12 19 More than one etiological agent may exist for the same type of tumor in animals of different genetic origins.
Earlier observations showed that mice from 3 of 7 inbred strains had high incidences of lymphoid tumors when estrogens were injected.12 Very few estrogen-treated animals from two strains showed lymphoid tumors. For the present experiments hybrid mice were obtained by mating males and females of six different inbred strains (table 1) to determine the extent to which the susceptibility to the estrogen induction of lymphoid tumors might be transmitted. given one of several different estrogens or doses of estrogens. The 'estrogens,* estradiol benzoate, stilbestrol, estrone, and estradiol dipropionate were administered in solution in sesame oil or as pellets of the pure crystalline hormone, or as pellets of the hormone mixed with cholesterol. The weekly subcutaneous doses of estradiol benzoate were 16.6 ,ug. and 25 ,ug.; of stilbestrol, 250 Jug.; of estradiol dipropionate, 10 ,ug., 25 pug., or 50 /-&g. The pellets of estrone used weighed from 1.2 to 7 mg. They were weighed before they were implanted subcutaneously through a trocar and again weighed after they were removed at the time of autopsy. The pellets containing stilbestrol contained either 3 parts of cholesterol to 1 part of stilbestrol or 9 parts of cholesterol to 1 part of stilbestrol. The stilbestrol-cholesterol pellets were made by compression of the mixed and powdered crystals. The pellets implanted weighed from 4 to 8 mg. and were weighed again after their removal at autopsy. * The estradiol benzoate was supplied by the Schering Corporation by Dr. E. Schwenk; the estradiol dipropionate and estrone by Ciba Pharmaceutical Products; and the stilbestrol by the E. R. Squibb & Sons Company. The hormones were dissolved in oil so that the weekly dose was contained in 0.05 cc.
The estrogens were usually first administered when the animals were 30 to 40 days of age. The mice were observed until death, until tumors appeared, or until their general condition had deteriorated indicating the imminence of death. All animals were autopsied. If gross evidences of tumors were apparent, tissues were saved for histological examination after fixation in Bouin's fluid and staining with hematoxylin and triosin. The tissues usually studied in such animals were mediastinal masses of lymphoid tissue, the livers, spleens, kidneys, and lymph nodes. Occasionally infiltrations of malignant lymphocytes were also observed in the genital tissues, mammary glands, adrenal glands, or other tissues, which were also examined routinely in connection with other phases of this study.
The mice were kept in the same room of an air-conditioned laboratory. They were fed Purina fox chow and water.
Litter-mates were used in both the control and experimental groups in so far as possible. A minimal number of breeding animals was used to supply the first generation hybrid offspring. A large number of progeny of one pair of breeders was available in numerous instances. 12 per cent of the animals (table 3). The total incidence of tumors* was similar to that observed among the estrogen-treated mice of the pure strains from which the hybrid mice were derived. The number of tumors among the untreated mice (4.5 per cent) was greater than among the control mice of the pure strains (1.34 per cent). Thirty-three of the 739 untreated hybrid mice had lymphoid tumors at death. The relatively high incidence among the control animals resulted from the frequent appearance of tumors among three groups, namely, the A71, A72, and JA2 groups (table 3) . Twenty-four of the 33 animals dying with tumors were among the 152 mice of these three groups, whereas only 9 tumors (1.5 per cent) were found among the 576 mice of the other 13 groups, an incidence comparable to that of the untreated mice of the parental strains.
Mice from the C3H, CBA, and PM strains showed high incidences of lymphoid tumors when subjected to high doses of estrogens for 10 weeks or more, whereas estrogen-treated mice of the A, JK, and C57 strains showed little or no leukemic response (table 1, Chart I). The incidence of spontaneous lymphoid neoplasia among these strains was also very low (0 to 5 per cent), but it was highest in the C57 strain.
When F1 hybrid mice of two strains (C3H x PM) that showed a marked increase of leukemia subsequent to estrogen treatment were treated in the same manner as animals of their parental strains the incidence of tumors was very high, reaching 40 and 45 per cent (tables 3 and 4). The incidence of lymphoid neoplasia was greater than it had been in either of the parental strains and it was similar in bo-th of the reciprocal crosses of PC groups, namely, the PC1 and PC2 groups. The absence of tumors among the untreated control mice of these groups contrasts with the high incidence among the treated mice, and again the observations were similar to those made upon the mice of the parental strains.
Five pairs of groups of hybrid mice were obtained by mating animals of one strain which showed a high incidence of leukemia *The word "tumor" used in this paper, unless otherwise indicated, refers to malignant lymphoid tumors of all types, that is, lymphatic leukemia, lymphosarcoma, Hybrid Groups CHART I. The incidence of lymphoid tumors among estrogen-treated and control mice of 6 inbred strains and of 16 first-generation hybrid groups derived from reciprocal crosses of males and females of these strains. The sections of the chart designated A, B, and C present the incidence of tumors among the offspring of two strains susceptible to estrogeninduced lymphomas, one susceptible and one resistant strain, and two resistant strains, respectively. cent for the mice of the AC, AB, HC, JC, and CC groups, respectively (tables 3 and 4).
The mice of the C3H and CBA strains contributed the susceptibility to lymphoid tumors in these groups and animals of the A, C57, or JK strains were the non-susceptible parents (tables 1 and 2). The incidences of lymphoid tumors were lower among the mice of these groups than in the group that had both parents from mice of the susceptible strains (tables 3 and 4). Four of the 5 groups of hybrids showed slightly higher incidences of lymphoid tumors when the mnaternal parents were from the more responsive C3H or CBA strains. Eight per cent of the AC1 mice died with lymphoid neoplasia in contrast to 10 per cent of the AC2 animals, although the latter lived, on the average, 34 days less than the former (tables 3 and 5). The lymphoid tumors also appeared nearly 50 days earlier in the mice of the AC2 group. Also among the AB, HC, and CC groups the incidence of tumors was highest when the mice of the CBA or C3H strains were the maternal parents (tables 3, 4, and 5).
The average periocds of survival of the mice with maternal parents of the tumor-susceptible groups were again shorter than those of the members of the reciprocal pairs with the A or C57 mothers. On the other hand, the hybrid mice of the JC groups had the highest incidence of lymphoid tumors when mice of the JK strain, which were not susceptible to estrogen-induced leukemia, were the maternal parents (tables 3 and 4). The tumors occurred in older animals in this group and at an average age of 453 days (table 5) . The hybrid mice obtained by mating animals from two strains which showed little or no increase in the incidence of leukemia subsequent to estrogen treatment differed greatly in their leukemic response to estrogen. Approximately 9 per cent of the A7 and none of the JA groups had lymphoid tumors (tables 3 and 4). On the other hand, from 11 to 20 per cent of the untreated controls died with lymphoid tumors (table 3) . It is of interest that the highest incidences of tumors which appeared among the control mice were in the groups least responsive to tumor induction subsequent to estrogen treatment.
The age of the animals as related to the appearance of leukemia Among the estrogen-treated mice the average ages at which lymphoid tumors appeared corresponded roughly to the average age of survival of all the mice among the several groups (table 5) . The youngest mouse to show a lymphoid tumor was 148 days old and from the HCO group. The average ages at the time leukemia appeared among the mice of the different groups ranged from 266 days to 453 days. The average ages at death of all of the mice from each of the 16 groups ranged from 254 to 392 days.
The untreated control mice of the 16 groups lived, on the average, from 291 to 717 days and the average ages at which lymphoid tumors appeared among the mice of these groups ranged from 462 to 863 days, in most instances well beyond the average ages at death of all of the animals in the groups (table 5). The average ages of the mice of 15 of the 16 control groups exceeded those of the estrogen-treated mice. The untreated mice acquired tumors when they were approximately twice as old as the animals in which such neoplasia appeared following estrogen treatment.
The average survivals of the two groups of control mice of each of the A7, AB, JA, HC, PC, and JC groups differed from each other. This was due to the high incidence of mammary tumors among the mice with the maternal parents of the A or C3H strains and the relative infrequency or late appearance of mammary tumors in the reciprocal hybrids with maternal parents of the JK, C57, PM, and CBA strains.
The influence of the effective dose of estrogen upon the incidence of tumors " The highest incidence of lymphoid tumors occurred among the mice which had received pellets of estrone or of stilbestrol and cholesterol (tables 4 and 6) . Of the mice of these groups 18 and 36 per cent died with tumors. The comparatively high incidence of tumors among the mice which received the pellets of stilbestrol and cholesterol might in part be attributed to the large number of animals in the PC groups subjected to such treatment. However, with the exception of the JA groups, all groups that received this treatment showed lymphoid tumors. The lowest incidence of tumors occurred among the mice that received weekly injections of 250 Vg. of stilbestrol. Although this is a large dose in terms of mouse units it is a relatively small effective dose when administered in one injection weekly. The mice receiving the oily solution of stilbestrol tolerated the treatment well.
The incidences of tumors among the two groups of mice receiving estradiol benzoate and the groups that received the larger doses of estradiol dipropionate were moderately high.
The above observations reveal that high effective doses of estrogen, especially continuous sources of hormone as provided by pellets, are most frequently accompanied by the appearance of lymphoid neo- Types of lymphomas among estrogen-treated hybrid and control mice The greater number of lymphoid tumors among both the control and the experimental animals were lymphomas similar to those in mice of the pure straiins. Most of the animals had tumors that apparently arose in the thymus and had infiltrated the adjacent pericardium, heart, large blood vessels, esophagus, and lungs, and often had invaded the intercostal musdes. Diffuse, or more rarely nodular, metastases to the livers, spleens, lymph nodes, and the kidneys occurred in many of the animals. A number of the mice also had a general infiltration of the adrenal glands, ovaries, and uteri.
Several of the mice had tumors composed primarily of mesenchymal cells of the reticular tissues and were classified as reticulum-cell sarcomas. In the animals bearing this type of tumor the extent of the mediastinal involvement and the sites of metastases were similar to those in the animals with the more usual types of lymphomas that consisted predominantly of lymphoblastic or of small lymphocytic cells. Sometimes it was difficult to ascertain whether or not hyper-plasias of the cells of the splenic and less frequently of the hepatic reticular tissues in some of the treated animals were malignant. No proliferations of the reticular cells were considered to be malignant unless there were distinct and extensive metastases.
Several animals in groups resulting from the crosses between the A and C57 strains of mice showed marked ectopic myelopoiesis. Sometimes it was difficult to determine whether or not these myeloid metaplasias were myelogenous leukemias. Many of them showed a preponderance of immature myeloid cells but usually they showed normoblastic cells as well. In none of the animals of the A7 groups, however, were unquestionably leukemic myeloid lesions found. One myelogenous leukemia was found among the control animals of the JA group. In this mouse all of the hematopoietic organs were grossly infiltrated by myeloid cells in all stages of differentiation. Two other unusual tumors occurred in mice of the JA2 group. These tumors were composed of mesenchymal cells and of cells of the normoblastic series in all stages of differentiation. The normoblastic cells constituted the greater part of the large mediastinal or thymic masses. The spleens, livers, kidneys, and mesenteric lymph nodes were also extensively infiltrated with immature red cells. Very few granulocytic elements of any type were found in any of the sites at which these two tumors were observed. Discussion TEhe experiments reported here were undertaken essentially for the purpose of studying the transmission of the tendency for mice to acquire mammary, hypophyseal, and testicular tumors subsequent to prolonged subjection to estrogens. It was known that estrogentreated mice of the A, C3H, and CBA strains acquired mammary tumors,18 that similarly treated mice of the A and JK strains acquired testicular tumors,10' 15 and that hypophyseal tumors appeared frequently only among estrogen-treated mice of the C57 strain.14 The maternal transmission of the tendency to have mammary tumors has been repeatedly demonstrated,2 and it has certainly been partially confirmed in these experiments. The strain-limited tendency for mice to acquire lymphoid tumors when exposed to prolonged treatment with effective amounts of estrogens was more recently revealed.'2 Within the same species, therefore, the same stimulus may result in the attainment of any one of several different types of neoplasia.
Both the male and female mice of the C57 strain when mated with members of the CBA strain transmitted to their first generation hybrid offspring the tendency to acquire hypophyseal tumors. 9 The CBA mice simultaneously transmitted to the hybrid offspring the tendency to acquire lymphoid tumors (table 3) . However, the female mice of the CBA strain predominantly transmitted the tendency to have mammary tumors or precancerorus mammary hyperplasias when similarly treated as noted among the animals of the CC2 group.9 Among the mice of this group mammary, lymphoid, and hypophyseal tumors arose, whereas in the reciprocal group, that is, among the CC1 group, only lymphoid and hypophyseal tumors occurred.
The tendency for the estrogen-treated mice of the CC groups to acquire hypophyseal tumors exceeded that of the susceptible C57 strain,9' 14 probably because of the increased tolerance of the hybrid animals to the estrogen and consequently their prolonged survival. The incidence of lymphoid tumors was somewhat lower ( 12 per cent) than that for the mice of the CBA strain ( 19 per cent) subjected to similar treatment. In other words, the tendency to acquire lymphoid tumors was intermediate between that of the two parental strains. In this respect the susceptibility to estrogeninduced leukemia was transmitted in a manner similar to the transmission of spontaneous leukemia. 22 The first generation hybrid offspring obtained by mating mice of other strains with high and low susceptibility to lymphoid tumors showed irregular tendencies to acquire tumors or tended to resemble the susceptible strains."7 18 The average ages at which tumors appeared were greater among the hybrid groups, however.3 18 Likewise, the average age of the tumorous mice of the hybrid groups exceeded that of the total population of each of the respective hybrid groups (table 5) .
The incidences of lymphoid tumors of the hybrid mice obtained by mating animals from other low-lymphoid-tumor strains with mice of the high-tumor CBA or C3H strains were also intermediate between the 2 parental groups, although in some the incidence was slightly higher than in others.
The first generation hybrid young (A7 and JA groups) of the strains (A, C57, and JK) which did not show lymphoid tumors subsequent to estrogen treatment showed different incidences of tumors. The A-groups had an incidence of tumors approximately the same as that of the preceding hybrid groups with parents of the C3H or CBA strain, and the JA groups had no lymphoid tumors. On the other hand, mice of 3 of the 4 hybrid groups showed a very high incidence of spontaneous tumors. The incidence of spontaneous tumors was greater than among the estrogen-treated mice. Tumors among the control mice, however, appeared in old animals.
The results obtained with the first generation hybrid offspring between mice of strains with contrasting susceptibilities to spontaneous or induced tumors have been sufficiently variable to prevent extensive generalization. Although the present data are not too extensive and some variability exists among the different groups with respect to the relative incidence 'of estrogen-induced lymphomas, it is indicated that a genetic transmission exists for the tendency to such neoplasia. In general, the tendency was transmitted equally by both males and females of the susceptible strains. Furth et al., on the other hand, observed a tendency for the hybrid young of susceptible X resistant parents to show a significantly lower incidence of spontaneous leukemia when the dam was from the resistant strain.7 The tendency for estrogen-induced leukemias among hybrid mice, as among the mice of the pure strains, could not be associated with the tendency to acquire spontaneous tumors.
The very high incidence of lymphoid tumors among the estrogentreated hybrid young of the C3H X PM groups reveals an augmenting influence. At the same time that the incidence of tumors was being so greatly increased among the treated animals, among the controls the relative number of lymphomas was not appreciably different from that in the parental strains. The longer survival of the estrogen-treated hybrid mice might account for a part of the elevated incidence of tumors. More hybrid mice, however, may acquire mammary tumors than either of their parent strains when maintained under similar conditions.' Similar tendencies have been observed among hybrid mice in this laboratory.
The actions of estrogenic hormones on lymphoid tissues have been discussed in a previous publication,12 and no significant additional information is available. The possibility that intrinsic estrogens may incite spontaneous leukemias has not been proved and does not seem too plausible. However, among mice of several strains or groups the number of lymphomas among the females exceeds that among the males.7
Some strains of mice are much more susceptible than are others to the development of lymphomas subsequent to the administration of carcinogens. 5 19, 20, 23 It is not known, however, how transmitted factors might alter the incidence in hybrid mice obtained by mating animals susceptible to the carcinogen-induced lymphomas with nonsusceptible animals, or how estrogens might act in combination with other leukemogenic agents. Carcinogens and roentgen rays may augment the incidence of leukemia in a synergistic manner in mice of some strains,6 but not of others. 16 Animals showing a leukemogenic response to estrogen, however, do not necessarily show a similar response to the carcinogenic hydrocarbons.12' 19 Carcinogenic hydrocarbons did not induce leukemia in mice of the C3H strain whereas estrogens were effective.
The specificity of action of different agents in eliciting the same neoplastic response in animals of different genetic groups is of considerable interest. The possibility that a multiplicity of stimuli may induce tumors of the same type in different animals will not simplify the problem. Summary 1. Hybrid mice of 16 different groups were either treated with one of several different estrogenic chemicals or maintained as untreated controls.
2. Of 1403 estrogen-treated mice 165, or approximately 12 per cent, died with lymphoid tumors and 34, or 4.5 per cent, of 739 control mice died with tumors of the same type.
3. Hybrid mice born of parents of two strains susceptible to estrogen-induced lymphomas had a high incidence of such tumors, 40 and 45 per cent, while no tumors occurred in the untreated controls.
4. Hybrid mice born of parents one of which was susceptible to estrogen-induced leukemia and one resistant showed incdences intermediate between the parental stocks.
S. Hybrid mice born of parents from two strains resistant to estrogen-induced leukemias had in one instance higher and in one instance lower incidences of lymphomas than the parental strains.
6. The incidence of spontaneous lymphomas among the untreated mice was high in three groups (11.5 to 20 per cent).
Among the mice of these groups the incidence of myeloid metaplasia was also high and two mice showed erythroblastic neoplasia. 7 . The lymphoid tumors were of the same types as described as occurring among mice of the parental inbred strains.
